Overview

Specific Interventions for Agitation in Alzheimer's Disease

Status:
Completed
Trial end date:
2005-01-01
Target enrollment:
Participant gender:
Summary
This study is aimed at investigating specific pharmacological interventions in the treatment of the disruptive, agitated behavior associated with Alzheimer's patients. In addition, it is hoped that specific clinical profiles will be found to predict which treatment is most effective for these particular patients.
Phase:
N/A
Details
Lead Sponsor:
US Department of Veterans Affairs
VA Office of Research and Development
Treatments:
Gabapentin
Risperidone